Congressional Testimony and Letters to Regulators ACA has been active in Washington, DC. Below are some of ACA's written testimony filings to Congressional committees and letters to the Securities and Exchange Commission: ACA Letter to SEC on Accredited Investor Definition - February 28, 2014 ACA Letter to SEC on Proposed Rule on Regulation D, Form D and Rule 156 - November 4, 2013 Mike Eckert in Senate Small Business and Entrepreneurship Committee Roundtable - July 17, 2013 Jean Peters to House Small Business Sub-Committee re JOBS Act - April 11, 2013 ACA Statement on General Solicitation and Verification of Accredited Investor Status to SEC - December 11, 2012 ACA Statement on General Solicitation and Verification of Accredited Investor Status to SEC - September 26, 2012 David Verrill to Senate Finance and House Ways & Means Committees - September 20, 2012 ACA Letter on General Solicitation and Verification of Accredited Investor Status to SEC - August 20, 2012 Tony Shipley to House Small Business Sub-Committee - April 19, 2012 ACA Public Statement on Crowdfunding Legislation - December 5, 2012 ACA Letter to SEC on Bad Actor Qualifications - July 14, 2011 ACA Attachment to SEC on Bad Actor Questionnaire - July 14, 2011 ACA Statement to SEC Government-Business Forum on Small Business Capital Formation - November 18, 2010